[ad_1] WASHINGTON, Oct. 19, 2024 /PRNewswire/ — The following statement is being issued regarding the Valeant Pharmaceuticals Fair Fund. UNITED STATES SECURITIES AND EXCHANGE COMMISSION In the Matter of Valeant Pharmaceuticals International, Inc. n/k/a […]










